Does BUPROPION HYDROBROMIDE Cause Hospitalisation? 30 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 30 reports of Hospitalisation have been filed in association with BUPROPION HYDROBROMIDE (Aplenzin). This represents 12.8% of all adverse event reports for BUPROPION HYDROBROMIDE.
30
Reports of Hospitalisation with BUPROPION HYDROBROMIDE
12.8%
of all BUPROPION HYDROBROMIDE reports
0
Deaths
30
Hospitalizations
How Dangerous Is Hospitalisation From BUPROPION HYDROBROMIDE?
Of the 30 reports, 30 (100.0%) required hospitalization.
Is Hospitalisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BUPROPION HYDROBROMIDE. However, 30 reports have been filed with the FAERS database.
What Other Side Effects Does BUPROPION HYDROBROMIDE Cause?
Headache (82)
Asthma (68)
Gastrooesophageal reflux disease (64)
Therapeutic product effect incomplete (61)
Wheezing (59)
Hypertension (55)
Fibromyalgia (46)
Blood test abnormal (45)
Burning sensation (45)
Cardiac disorder (45)
What Other Drugs Cause Hospitalisation?
CLOZAPINE (12,144)
CINACALCET (6,997)
DARBEPOETIN ALFA (5,682)
MACITENTAN (3,414)
APIXABAN (3,315)
ADALIMUMAB (3,033)
DUPILUMAB (2,529)
LENALIDOMIDE (2,241)
DENOSUMAB (2,076)
PALIPERIDONE (2,066)
Which BUPROPION HYDROBROMIDE Alternatives Have Lower Hospitalisation Risk?
BUPROPION HYDROBROMIDE vs BUPROPION\DEXTROMETHORPHAN HYDROBROMIDE
BUPROPION HYDROBROMIDE vs BUPROPION\NALTREXONE
BUPROPION HYDROBROMIDE vs BUROSUMAB
BUPROPION HYDROBROMIDE vs BUROSUMAB-TWZA
BUPROPION HYDROBROMIDE vs BUSPIRONE